CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice

CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice
复制标题

DOI:
10.1073/pnas.101123098
复制
发表时间:
2001-05-22
影响因子:
11.1
通讯作者:
Chess, L
Chess, L
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Jiang, H;Braunstein, NS;Chess, L

文献摘要

被引文献

相似文献

T细胞抗原受体和MHC/肽复合物之间的三分子相互作用,以及共刺激分子和细胞因子,控制初始T细胞的活化,并决定是否辅助前体细胞分化成T辅助(TH)1或TH 2效应细胞。我们现在提出的证据表明,调节性CD 8(+)T细胞在免疫应答的进一步进化过程中提供了另一个水平的TH表型控制。这些调节性CD 8(+)T细胞在T细胞接种期间由抗原触发的CD 4(+)TH 1细胞诱导,并且在体外以T细胞抗原受体VP特异性和Qa-1限制性方式区分成熟的TH 1和TH 2细胞。在体内,对由T细胞接种诱导的实验性自身免疫性脑脊髓炎(EAE)的保护依赖于CD 8(+)T细胞,并且髓磷脂碱性蛋白反应性TH 1 V β 8(+)克隆,而不是TH 2 V β 8(+)克隆,用作疫苗T细胞,保护动物免于随后诱导的EAE。此外,在EAE第一次发作期间体内CD 8(+)T细胞的耗竭导致TH表型在继发性髓鞘碱性蛋白刺激后向TH 1倾斜。这些数据提供的证据表明,CD 8(+)T细胞控制自身免疫反应,部分是通过调节自身反应性CD 4(+)T细胞的TH表型。
Trimolecular interactions between the T cell antigen receptor and MHC/peptide complexes, together with costimulatory molecules and cytokines, control the initial activation of naive T cells and determine whether the helper precursor cell differentiates into either T helper (TH)1 or TH2 effector cells. We now present evidence that regulatory CD8(+) T cells provide another level of control of TH phenotype during further evolution of immune responses. These regulatory CD8(+) T cells are induced by antigen-triggered CD4(+) TH1 cells during T cell vaccination and, in vitro, distinguish mature TH1 from TH2 cells in a T cell antigen receptor VP-specific and Qa-1-restricted manner. In vivo, protection from experimental autoimmune encephalomyelitis (EAE) induced by T cell vaccination depends on CD8(+) T cells, and myelin basic protein-reactive TH1 V beta8(+) clones, but not TH2 V beta8(+) clones, used as vaccine T cells, protect animals from subsequent induction of EAE. Moreover, in vivo depletion of CD8(+) T cells during the first episode of EAE results in skewing of the TH phenotype toward TH1 upon secondary myelin basic protein stimulation. These data provide evidence that CD8(+) T cells control autoimmune responses, in part, by regulating the TH phenotype of self-reactive CD4(+) T cells.